The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells

Mohammad Hojjat-Farsangi; Abdul Salam Khan; Amir Hossein Daneshmanesh; Ali Moshfegh; Åsa Sandin; Ladan Mansouri; Marzia Palma; Jeanette Lundin; Anders Österborg; Håkan Mellstedt

doi:10.1371/journal.pone.0078339

Loading metrics

Open Access

Peer-reviewed

Research Article

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells

Mohammad Hojjat-Farsangi,

Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Abdul Salam Khan,

Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Amir Hossein Daneshmanesh,

Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Ali Moshfegh,

Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Åsa Sandin,

Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Ladan Mansouri,

Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Marzia Palma,

Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Departments of Oncology and Hematology, Karolinska University Hospital Solna, Stockholm, Sweden
⨯
Jeanette Lundin,

Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Departments of Oncology and Hematology, Karolinska University Hospital Solna, Stockholm, Sweden
⨯
Anders Österborg,

Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Departments of Oncology and Hematology, Karolinska University Hospital Solna, Stockholm, Sweden
⨯
Håkan Mellstedt

* E-mail: hakan.mellstedt@karolinska.se

Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Departments of Oncology and Hematology, Karolinska University Hospital Solna, Stockholm, Sweden
⨯

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells

Mohammad Hojjat-Farsangi,
Abdul Salam Khan,
Amir Hossein Daneshmanesh,
Ali Moshfegh,
Åsa Sandin,
Ladan Mansouri,
Marzia Palma,
Jeanette Lundin,
Anders Österborg,
Håkan Mellstedt

Published: October 24, 2013
https://doi.org/10.1371/journal.pone.0078339

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Chronic lymphoblastic leukemia
Is the Subject Area "Chronic lymphoblastic leukemia" applicable to this article?

Thanks for your feedback.
Tyrosine kinases
Is the Subject Area "Tyrosine kinases" applicable to this article?

Thanks for your feedback.
Serine
Is the Subject Area "Serine" applicable to this article?

Thanks for your feedback.
Immunoprecipitation
Is the Subject Area "Immunoprecipitation" applicable to this article?

Thanks for your feedback.
Leukemia
Is the Subject Area "Leukemia" applicable to this article?

Thanks for your feedback.
Tyrosine
Is the Subject Area "Tyrosine" applicable to this article?

Thanks for your feedback.